MedTrace Logo

Allergen Challenge Trial of IRL201104 in Seasonal Allergic Rhinitis

NCT05098522 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 63

Last updated 2023-05-03

No results posted yet for this study

Summary

The purpose of this allergen challenge study is to assess the efficacy of IRL201104 compared with placebo in adult participants with seasonal allergic rhinitis.

Conditions

  • Seasonal Allergic Rhinitis

Interventions

DRUG

IRL201104

lyophilised powder for reconstitution for IV dosing

DRUG

Placebo

Matching placebo for IRL201104

Sponsors & Collaborators

  • Revolo Biotherapeutics

    lead INDUSTRY

Principal Investigators

  • Anoshie Ratnayake, MD · Revolo Biotherapeutics

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-04
Primary Completion
2023-03-27
Completion
2023-03-27

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05098522 on ClinicalTrials.gov